Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
AILERON THERAPEUTICS INC
|
D | 2009-06-11 |
Amount To Be Raised
$40,150,000
Associated Brokers / Dealers
N/A
CIK Number
0001420565
Filed Document
0001420565-09-000003
Exclusions or Exemptions
N/A
Accepted Date
2009-06-11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
AILERON THERAPEUTICS INC
|
D | 2013-11-18 |
Amount To Be Raised
$30,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001420565
Filed Document
0001420565-13-000001
Exclusions or Exemptions
506b
Accepted Date
2013-11-18
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
AILERON THERAPEUTICS INC
|
D | 2023-11-16 08:05:50 |
Amount To Be Raised
$18,254,247
Associated Brokers / Dealers
N/A
CIK Number
0001420565
Filed Document
0001420565-23-000002
Exclusions or Exemptions
506b
Accepted Date
2023-11-16 08:05:50
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
AILERON THERAPEUTICS INC
|
D | 2014-10-29 |
Amount To Be Raised
$32,999,999
Associated Brokers / Dealers
N/A
CIK Number
0001420565
Filed Document
0001420565-14-000002
Exclusions or Exemptions
506b
Accepted Date
2014-10-29
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
AILERON THERAPEUTICS INC
|
D | 2017-01-06 12:32:22 |
Amount To Be Raised
$40,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001420565
Filed Document
0001420565-17-000001
Exclusions or Exemptions
506b
Accepted Date
2017-01-06 12:32:22
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|